Becton Dickinson Shares Fall 17% YTD Below Fair Value Estimate

Becton Dickinson (BDX) shares have experienced subdued trading recently, following a challenging year with a year-to-date price return of -17.64%. The stock is currently trading below analyst targets and intrinsic value, with a last close at $186.53 compared to a narrative fair value of $208, reflecting potential undervaluation amid expectations of earnings acceleration and strategic shifts. However, risks such as trade headwinds and uncertainties around planned business separation may impact future earnings and margin improvements. Medtronic PLC (MDT) shares declined 1.76%, closing at $94.21, underperforming despite a strong overall market session. AbbVie Inc. (ABBV) also saw a 1.17% drop to $228.68 amid a broadly negative market day, marking its second consecutive day of losses. These healthcare stocks show mixed performance, influenced by broader market conditions and company-specific factors.